Sm. Griffey et al., Proliferation indices in spontaneous canine lung cancer: Proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts, J COMP PATH, 120(4), 1999, pp. 321-332
Citations number
17
Categorie Soggetti
Veterinary Medicine/Animal Health","Medical Research Diagnosis & Treatment
Proliferation indices were measured for specimens from 55 spontaneous canin
e lung tumours, collected by surgical biopsy from clinical patients and arc
hived in paraffin wax blocks. These indices were then related to the mitoti
c index and histological type of the tumour. Proliferating cell nuclear ant
igen (PCNA) and Ki-67 (MIB1) proteins were detected immunohistochemically w
ith a biotin-streptavidin amplified detection system on a representative ti
ssue section from each tumour. Five adjacent, non-overlapping fields were s
elected at random, and 200 cells per field were examined in each section. F
or PCNA, cells were classified subjectively into negative, weak or strong r
eactivity groups, based on nuclear staining. MIB1 cells were classified as
negative or positive, based on nuclear staining. Mitotic figures were count
ed in anti-PCNA-labelled and anti-MIB1-labelled sections, in the same tumou
r areas as those in which indices were established. Mitotic counts were als
o done on haematoxylin and eosin-stained tissue sections. Linear regression
analysis showed that all PCNA, MIB1 and mitotic indices had highly signifi
cant positive correlations (P < 0.0001) with each other. Adenosquamous and
squamous cell carcinomas differed from other histological tumour types in h
aving significantly higher proliferation indices. These data suggest that g
rowth rates for lung rumours in the dog vary according to histological type
. On the basis of differences in proliferation indices and the distribution
of immunoreactivity between histological subtypes in this study; it would
seem that immunohistochemical detection of PCNA and MIB/1 reactivity and an
alysis of mitotic figures in routinely processed tissues may be useful in t
he diagnosis of lung tumours. (C) 1999 W.B. Saunders Company Limited.